1. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999; 94:2467–74.
Article
2. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for non-alcoholic fatty liver disease. Hepatology. 2005; 41:1313–21.
Article
3. Bedossa P, Consortium FP. Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease. Hepatology. 2014; 60:565–75.
Article
4. Bedossa P, Poitou C, Veyrie N, et al. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. Hepatology. 2012; 56:1751–9.
Article
5. Alkhouri N, De Vito R, Alisi A, et al. Development and validation of a new histological score for pediatric non-alcoholic fatty liver disease. J Hepatol. 2012; 57:1312–8.
Article
6. Jung ES, Lee K, Yu E, et al. Interobserver agreement on pathologic features of liver biopsy tissue in patients with nonalcoholic fatty liver disease. J Pathol Transl Med. 2016; 50:190–6.
Article
7. Randolph JJ. Free-marginal multirater kappa (multirater κfree): an alternative to Fleiss fixed-marginal multirater kappa. In : Joensuu Learning and Learning Symposium; 2005 Oct 14-15; Joensuu, Finland.
9. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 1980; 55:434–8.
10. Pournik O, Alavian SM, Ghalichi L, et al. Inter-observer and intraobserver agreement in pathological evaluation of non-alcoholic fatty liver disease suspected liver biopsies. Hepat Mon. 2014; 14:e15167.
Article
11. Hjelkrem M, Stauch C, Shaw J, Harrison SA. Validation of the nonalcoholic fatty liver disease activity score. Aliment Pharmacol Ther. 2011; 34:214–8.
Article
12. Rastogi A, Shasthry SM, Agarwal A, et al. Non-alcoholic fatty liver disease: histological scoring systems: a large cohort single-center, evaluation study. APMIS. 2017; 125:962–73.
13. Angulo P, Kleiner DE, Dam-Larsen S, et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2015; 149:389–97.
Article